Literature DB >> 23051784

Level of evidence in anterior cruciate ligament reconstruction research: a systematic review.

Kristian Samuelsson1, Neel Desai, Erik McNair, Carola F van Eck, Max Petzold, Freddie H Fu, Mohit Bhandari, Jón Karlsson.   

Abstract

BACKGROUND: There have been numerous studies on anterior cruciate ligament (ACL) reconstruction. Considering the vast number of studies, a quick assessment reveals rather few with a high level of evidence.
PURPOSE: The primary aim was to categorize the study type and level of evidence of studies on primary ACL reconstruction by applying the level of evidence rating system proposed by the Oxford Centre for Evidence-Based Medicine. The secondary aims were to correlate the level of evidence with the impact factor of the journal, to evaluate the level of evidence over time, and to evaluate the geographic distribution of the included studies. STUDY
DESIGN: Systematic review.
METHODS: An electronic search was performed using the databases PubMed, EMBASE, and Cochrane Library. Studies published from January 1995 to August 2011 were included. Therapeutic studies written in English that report on isolated primary ACL reconstruction with clinical outcome measurements related to the reconstruction were included. Categorization and implementation of the level of evidence were performed. Correlation between the level of evidence and the impact factor of the journal was analyzed together with linear regression models to reveal any significant trends over time.
RESULTS: A total of 7154 studies were analyzed, of which 1510 were included. Analysis of the study types revealed that case series (n = 494; 32.7%) was the most frequent study type. Randomized controlled trials represented 9.2% (n = 139) of the sample, whereas meta-analyses were rare. Single-bundle studies were the most common studies (n = 1333; 88.3%), followed by double-bundle (n = 98; 6.5%) and single- versus double-bundle (n = 79; 5.2%). The journals Arthroscopy, Knee Surgery Sports Traumatology Arthroscopy (KSSTA), and American Journal of Sports Medicine (AJSM) represented 43.5% (n = 657) of the included studies. Arthroscopy had the highest number of publications in general and in level 4 and 5 studies, whereas AJSM had the lowest number of the 3. AJSM had the highest number of level 1 and 2 studies in general. The mean level of evidence calculated without level 5 studies was 3.15 for Arthroscopy, 3.20 for KSSTA, and 2.9 for AJSM. There was a significant correlation (P < .05) between the impact factor of the journal and mean level of evidence of the journal and the proportion high level of evidence studies (levels 1 and 2). There was a significant (P < .05) trend toward higher mean level of evidence over time.
CONCLUSION: Most therapeutic studies on primary ACL reconstruction were of low level of evidence, and there was a positive correlation between the journal's impact factor and the mean level of evidence and the proportion of high level of evidence studies. There was significant trend toward higher mean level of evidence over time.

Entities:  

Mesh:

Year:  2012        PMID: 23051784     DOI: 10.1177/0363546512460647

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  11 in total

Review 1.  What are the levels of evidence on which we base decisions for surgical management of lower extremity bone tumors?

Authors:  Nathan Evaniew; James Nuttall; Forough Farrokhyar; Mohit Bhandari; Michelle Ghert
Journal:  Clin Orthop Relat Res       Date:  2013-10-01       Impact factor: 4.176

2.  Statistics in Brief: An Introduction to the Use of Propensity Scores.

Authors:  Maria C S Inacio; Yuexin Chen; Elizabeth W Paxton; Robert S Namba; Steven M Kurtz; Guy Cafri
Journal:  Clin Orthop Relat Res       Date:  2015-03-13       Impact factor: 4.176

3.  Morphologic evaluation of remnant anterior cruciate ligament bundles after injury with three-dimensional computed tomography.

Authors:  Nobuo Adachi; Mitsuo Ochi; Kobun Takazawa; Minoru Ishifuro; Masataka Deie; Atsuo Nakamae; Goki Kamei
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-10-07       Impact factor: 4.342

Review 4.  A systematic review of single- versus double-bundle ACL reconstruction using the anatomic anterior cruciate ligament reconstruction scoring checklist.

Authors:  Neel Desai; Eduard Alentorn-Geli; Carola F van Eck; Volker Musahl; Freddie H Fu; Jón Karlsson; Kristian Samuelsson
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-10-26       Impact factor: 4.342

Review 5.  Level of evidence and authorship trends of clinical studies in knee surgery, sports traumatology, arthroscopy, 1995-2015.

Authors:  Ryan P Judy; Jason J Shin; Christopher McCrum; Olufemi R Ayeni; Kristian Samuelsson; Volker Musahl
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-11-14       Impact factor: 4.342

6.  Anterior cruciate ligament injury diagnosis and management in a pediatric patient: a case report.

Authors:  Charles Hazle; Cherie Duby
Journal:  Int J Sports Phys Ther       Date:  2012-12

7.  Anatomic single- versus double-bundle ACL reconstruction: a meta-analysis.

Authors:  Neel Desai; Haukur Björnsson; Volker Musahl; Mohit Bhandari; Max Petzold; Freddie H Fu; Kristian Samuelsson
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-12-17       Impact factor: 4.342

8.  Ten Years of Sports Health: Authorship Characteristics and Levels of Evidence.

Authors:  Ryan P Judy; Spencer Talentino; Asheesh Bedi; Bryson P Lesniak
Journal:  Sports Health       Date:  2020-07-06       Impact factor: 3.843

9.  Levels of Evidence in the Treatment of Slipped Capital Femoral Epiphysis: A Systematic Review.

Authors:  Andrew Moriarity; Jim Kennedy; Joe Baker; Pat Kiely
Journal:  Orthop Rev (Pavia)       Date:  2016-06-27

10.  A Systematic Summary of Systematic Reviews on the Topic of the Anterior Cruciate Ligament.

Authors:  Michael J Anderson; William M Browning; Christopher E Urband; Melissa A Kluczynski; Leslie J Bisson
Journal:  Orthop J Sports Med       Date:  2016-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.